A Phase 1 Clinical Trial for PlasProtecT – A Potential Cure for Malaria
Granted to Griffith University
Goal
To assist with the advancement of a novel malaria vaccine developed to induce immunity to all strains of the malaria parasite, which will reduce the loss of one-million lives, mainly children, to the disease annually.
Grant Amount
$722,159
Local Currency
A$743,000
Year Awarded
2011
Term
42 Months